Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nkx2-3
|
ENSMUSG00000044220.12 | NK2 homeobox 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr19_43616627_43617285 | Nkx2-3 | 4631 | 0.121111 | 0.67 | 1.9e-08 | Click! |
chr19_43616398_43616585 | Nkx2-3 | 4166 | 0.125712 | 0.66 | 3.2e-08 | Click! |
chr19_43616167_43616368 | Nkx2-3 | 3942 | 0.128428 | 0.65 | 9.5e-08 | Click! |
chr19_43615213_43615390 | Nkx2-3 | 2976 | 0.146854 | 0.56 | 8.0e-06 | Click! |
chr19_43614850_43615114 | Nkx2-3 | 2657 | 0.157168 | 0.55 | 1.4e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr15_74194149_74194481 | 11.17 |
Gm15387 |
predicted gene 15387 |
99982 |
0.07 |
chrX_58445733_58445903 | 8.96 |
Gm14645 |
predicted gene 14645 |
17743 |
0.26 |
chr12_39301586_39301824 | 8.93 |
Gm18591 |
predicted gene, 18591 |
92813 |
0.08 |
chr10_102238764_102238956 | 8.72 |
Mgat4c |
MGAT4 family, member C |
79781 |
0.1 |
chr6_107711195_107711474 | 8.07 |
4933431M02Rik |
RIKEN cDNA 4933431M02 gene |
83560 |
0.1 |
chr13_107247476_107247653 | 7.65 |
Gm2726 |
predicted gene 2726 |
32627 |
0.2 |
chr3_6886780_6886981 | 7.61 |
Gm22074 |
predicted gene, 22074 |
90388 |
0.09 |
chr6_127701185_127701975 | 7.01 |
Gm43634 |
predicted gene 43634 |
57140 |
0.08 |
chr17_65961618_65962124 | 6.75 |
Ankrd12 |
ankyrin repeat domain 12 |
10521 |
0.14 |
chr3_139885937_139886924 | 6.67 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr1_29217161_29217338 | 6.23 |
Gm18033 |
predicted gene, 18033 |
2451 |
0.41 |
chr8_98573232_98573407 | 5.97 |
Gm23494 |
predicted gene, 23494 |
101883 |
0.08 |
chr9_50245051_50245269 | 5.87 |
2310003N18Rik |
RIKEN cDNA 2310003N18 gene |
11978 |
0.19 |
chr1_59394623_59395231 | 5.87 |
Gm29016 |
predicted gene 29016 |
15997 |
0.18 |
chr3_3832009_3832194 | 5.65 |
Gm2071 |
predicted gene 2071 |
2817 |
0.34 |
chr9_99994460_99994673 | 5.64 |
4930519F24Rik |
RIKEN cDNA 4930519F24 gene |
27734 |
0.17 |
chr13_84056961_84057458 | 5.62 |
Gm17750 |
predicted gene, 17750 |
7563 |
0.22 |
chr14_123065129_123065306 | 5.51 |
AA536875 |
expressed sequence AA536875 |
21935 |
0.22 |
chr13_77892438_77892993 | 5.51 |
Pou5f2 |
POU domain class 5, transcription factor 2 |
132187 |
0.05 |
chrX_93310672_93310849 | 5.41 |
Arx |
aristaless related homeobox |
24250 |
0.21 |
chr14_59737148_59737645 | 5.29 |
Gm19716 |
predicted gene, 19716 |
94848 |
0.07 |
chr14_123065358_123065532 | 5.29 |
AA536875 |
expressed sequence AA536875 |
22163 |
0.22 |
chr12_27076136_27076315 | 5.28 |
Gm9866 |
predicted gene 9866 |
38770 |
0.22 |
chr14_62415985_62416195 | 5.24 |
Gucy1b2 |
guanylate cyclase 1, soluble, beta 2 |
38703 |
0.13 |
chr6_138419995_138420190 | 5.22 |
Lmo3 |
LIM domain only 3 |
1360 |
0.42 |
chr5_42067440_42068088 | 5.20 |
Gm16223 |
predicted gene 16223 |
196 |
0.97 |
chr13_83985066_83985623 | 5.13 |
Gm4241 |
predicted gene 4241 |
2647 |
0.28 |
chr14_12876868_12877121 | 5.07 |
Gm5457 |
predicted pseudogene 5457 |
9441 |
0.24 |
chr16_63747767_63748162 | 5.05 |
Gm22769 |
predicted gene, 22769 |
430 |
0.91 |
chr2_117439884_117440216 | 5.03 |
Gm13982 |
predicted gene 13982 |
22353 |
0.24 |
chr3_26641406_26641733 | 5.00 |
Spata16 |
spermatogenesis associated 16 |
3919 |
0.29 |
chr1_78167977_78168321 | 4.95 |
Pax3 |
paired box 3 |
28689 |
0.2 |
chr2_101592687_101592869 | 4.91 |
B230118H07Rik |
RIKEN cDNA B230118H07 gene |
7844 |
0.19 |
chr17_66869624_66870037 | 4.90 |
Gm49940 |
predicted gene, 49940 |
7590 |
0.18 |
chr5_40295141_40295321 | 4.89 |
Gm2810 |
predicted pseudogene 2810 |
33207 |
0.24 |
chr14_105851771_105851979 | 4.87 |
Gm48970 |
predicted gene, 48970 |
10626 |
0.21 |
chr13_83750227_83750397 | 4.85 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
11449 |
0.12 |
chr5_44473970_44474128 | 4.79 |
Gm42981 |
predicted gene 42981 |
21372 |
0.13 |
chr10_69465967_69466180 | 4.77 |
Gm18636 |
predicted gene, 18636 |
42325 |
0.15 |
chr9_100686243_100686394 | 4.75 |
Gm38297 |
predicted gene, 38297 |
16895 |
0.16 |
chr10_19310105_19310477 | 4.74 |
Gm33056 |
predicted gene, 33056 |
19302 |
0.19 |
chr14_12338097_12338549 | 4.73 |
Gm24578 |
predicted gene, 24578 |
4419 |
0.14 |
chr9_65267989_65268185 | 4.72 |
Cilp |
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase |
2264 |
0.19 |
chr13_36283484_36283656 | 4.68 |
Gm48766 |
predicted gene, 48766 |
31211 |
0.17 |
chr7_132731406_132731752 | 4.67 |
Fam53b |
family with sequence similarity 53, member B |
45337 |
0.12 |
chr3_6886610_6886763 | 4.66 |
Gm22074 |
predicted gene, 22074 |
90582 |
0.09 |
chr16_77291582_77292053 | 4.66 |
Gm31258 |
predicted gene, 31258 |
13743 |
0.19 |
chr14_115082136_115082318 | 4.64 |
Gpc5 |
glypican 5 |
9988 |
0.13 |
chr17_17409158_17409446 | 4.60 |
Gm26873 |
predicted gene, 26873 |
2691 |
0.21 |
chr17_88763479_88763727 | 4.59 |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
10453 |
0.24 |
chr12_50190972_50191191 | 4.59 |
Gm40418 |
predicted gene, 40418 |
70772 |
0.14 |
chr14_100714045_100714196 | 4.57 |
Gm22401 |
predicted gene, 22401 |
13499 |
0.21 |
chr13_77893040_77893199 | 4.56 |
Pou5f2 |
POU domain class 5, transcription factor 2 |
131783 |
0.05 |
chr11_40456488_40456834 | 4.53 |
3110004A20Rik |
RIKEN cDNA 3110004A20 gene |
19016 |
0.17 |
chr18_57704186_57704540 | 4.50 |
Gm44491 |
predicted gene, 44491 |
22549 |
0.17 |
chr3_11261156_11261347 | 4.48 |
Gm22547 |
predicted gene, 22547 |
106914 |
0.08 |
chr3_26640780_26641306 | 4.45 |
Spata16 |
spermatogenesis associated 16 |
3393 |
0.31 |
chr10_29143863_29144732 | 4.44 |
Gm9996 |
predicted gene 9996 |
103 |
0.69 |
chr6_47229035_47229229 | 4.44 |
Cntnap2 |
contactin associated protein-like 2 |
15255 |
0.28 |
chr12_27151151_27151367 | 4.43 |
Gm9866 |
predicted gene 9866 |
9052 |
0.3 |
chr5_103161672_103161823 | 4.43 |
Mapk10 |
mitogen-activated protein kinase 10 |
44182 |
0.17 |
chr5_13414234_13414411 | 4.42 |
Sema3a |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
14745 |
0.24 |
chr13_99444397_99444879 | 4.39 |
Map1b |
microtubule-associated protein 1B |
171 |
0.95 |
chr5_111944379_111944557 | 4.37 |
Gm42488 |
predicted gene 42488 |
233 |
0.96 |
chr4_5962411_5962640 | 4.37 |
Gm11796 |
predicted gene 11796 |
107038 |
0.07 |
chr14_75473074_75473492 | 4.37 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
17301 |
0.22 |
chr6_15397521_15397861 | 4.36 |
Gm25470 |
predicted gene, 25470 |
7290 |
0.26 |
chr14_75236389_75236560 | 4.35 |
Cpb2 |
carboxypeptidase B2 (plasma) |
5813 |
0.15 |
chr15_85463386_85463550 | 4.35 |
7530416G11Rik |
RIKEN cDNA 7530416G11 gene |
39759 |
0.14 |
chr16_89530496_89531006 | 4.33 |
Krtap7-1 |
keratin associated protein 7-1 |
22428 |
0.15 |
chr7_97391358_97391780 | 4.33 |
Alg8 |
asparagine-linked glycosylation 8 (alpha-1,3-glucosyltransferase) |
791 |
0.53 |
chr13_112165997_112166183 | 4.31 |
Gm48802 |
predicted gene, 48802 |
5978 |
0.21 |
chr5_106577659_106577832 | 4.29 |
Gm29464 |
predicted gene 29464 |
2870 |
0.18 |
chr10_91514578_91514763 | 4.23 |
Gm47084 |
predicted gene, 47084 |
66290 |
0.12 |
chr2_51087621_51088075 | 4.21 |
Rnd3 |
Rho family GTPase 3 |
61246 |
0.13 |
chr15_44705846_44706012 | 4.20 |
Sybu |
syntabulin (syntaxin-interacting) |
41859 |
0.15 |
chr13_72298631_72298782 | 4.19 |
Gm4052 |
predicted gene 4052 |
51515 |
0.15 |
chr1_46830172_46830391 | 4.19 |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
5618 |
0.22 |
chr15_88315161_88315318 | 4.18 |
B230214G05Rik |
RIKEN cDNA B230214G05 gene |
365 |
0.51 |
chr18_46067126_46067291 | 4.17 |
A330093E20Rik |
RIKEN cDNA A330093E20 gene |
21948 |
0.2 |
chr8_69149162_69149554 | 4.17 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
8405 |
0.17 |
chr1_194226946_194227113 | 4.15 |
4930503O07Rik |
RIKEN cDNA 4930503O07 gene |
4270 |
0.36 |
chr15_22152009_22152160 | 4.13 |
Gm27525 |
predicted gene, 27525 |
121986 |
0.06 |
chr13_99443818_99444236 | 4.13 |
Map1b |
microtubule-associated protein 1B |
83 |
0.97 |
chr8_36014873_36015024 | 4.12 |
Rps12-ps24 |
ribosomal protein S12, pseudogene 24 |
10805 |
0.2 |
chr3_120342836_120343020 | 4.11 |
Gm23733 |
predicted gene, 23733 |
24939 |
0.27 |
chr19_15803250_15803445 | 4.10 |
Gm50348 |
predicted gene, 50348 |
289 |
0.94 |
chr10_25024228_25024379 | 4.10 |
Gm47715 |
predicted gene, 47715 |
24283 |
0.15 |
chr12_68217227_68217378 | 4.09 |
Gm47454 |
predicted gene, 47454 |
115320 |
0.06 |
chr5_81359614_81359973 | 4.08 |
Adgrl3 |
adhesion G protein-coupled receptor L3 |
49768 |
0.18 |
chr7_69572988_69573508 | 4.08 |
Gm44535 |
predicted gene 44535 |
6460 |
0.22 |
chr13_36283759_36283936 | 4.07 |
Gm48766 |
predicted gene, 48766 |
31488 |
0.17 |
chr4_125545547_125545968 | 4.07 |
Mir692-2 |
microRNA 692-2 |
41008 |
0.15 |
chr6_116397661_116398032 | 4.05 |
Marchf8 |
membrane associated ring-CH-type finger 8 |
5146 |
0.13 |
chr15_26275989_26276253 | 4.04 |
Marchf11 |
membrane associated ring-CH-type finger 11 |
32927 |
0.23 |
chr13_84752343_84752734 | 4.04 |
Gm26913 |
predicted gene, 26913 |
61597 |
0.15 |
chr16_91140532_91140860 | 4.04 |
Gm49612 |
predicted gene, 49612 |
5220 |
0.12 |
chr16_59854456_59854822 | 4.03 |
Epha6 |
Eph receptor A6 |
151082 |
0.04 |
chr3_156904026_156904232 | 4.00 |
Gm15577 |
predicted gene 15577 |
16651 |
0.23 |
chr3_66746460_66746680 | 3.99 |
Gm6555 |
predicted gene 6555 |
135780 |
0.05 |
chr16_52387159_52387325 | 3.99 |
Alcam |
activated leukocyte cell adhesion molecule |
65223 |
0.14 |
chr2_152048577_152049360 | 3.98 |
AA387200 |
expressed sequence AA387200 |
27840 |
0.11 |
chr1_20428787_20428938 | 3.98 |
Gm15795 |
predicted gene 15795 |
15948 |
0.17 |
chr17_4177609_4177825 | 3.98 |
4930548J01Rik |
RIKEN cDNA 4930548J01 gene |
55604 |
0.16 |
chr2_56539846_56540169 | 3.98 |
Mir195b |
microRNA 195b |
245804 |
0.02 |
chr8_48322987_48323138 | 3.97 |
Tenm3 |
teneurin transmembrane protein 3 |
22963 |
0.23 |
chr2_140669081_140669241 | 3.97 |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
2239 |
0.46 |
chr2_40643950_40644201 | 3.96 |
Lrp1b |
low density lipoprotein-related protein 1B |
13313 |
0.29 |
chr3_118664419_118664570 | 3.95 |
Dpyd |
dihydropyrimidine dehydrogenase |
102308 |
0.07 |
chr3_115856880_115857079 | 3.92 |
Dph5 |
diphthamide biosynthesis 5 |
30858 |
0.11 |
chr16_63278367_63278696 | 3.92 |
Gm33912 |
predicted gene, 33912 |
61089 |
0.15 |
chr13_89881342_89881539 | 3.92 |
Gm24498 |
predicted gene, 24498 |
46103 |
0.17 |
chrX_22950779_22950930 | 3.92 |
Gm26131 |
predicted gene, 26131 |
88918 |
0.1 |
chr10_83106435_83106654 | 3.91 |
1700025N21Rik |
RIKEN cDNA 1700025N21 gene |
35494 |
0.15 |
chr2_41498755_41498942 | 3.90 |
Lrp1b |
low density lipoprotein-related protein 1B |
290230 |
0.01 |
chr4_54331384_54331565 | 3.90 |
Gm12469 |
predicted gene 12469 |
95598 |
0.08 |
chr14_58101525_58101676 | 3.88 |
Gm17109 |
predicted gene 17109 |
4529 |
0.22 |
chr12_33035439_33035619 | 3.88 |
Cdhr3 |
cadherin-related family member 3 |
17457 |
0.14 |
chr4_148291962_148292123 | 3.87 |
Disp3 |
dispatched RND transporter family member 3 |
4077 |
0.19 |
chr7_54782042_54782216 | 3.84 |
Luzp2 |
leucine zipper protein 2 |
53369 |
0.15 |
chr8_97477153_97477340 | 3.84 |
Gm5913 |
predicted gene 5913 |
48136 |
0.17 |
chr14_16200927_16201541 | 3.84 |
Rpl31-ps3 |
ribosomal protein L31, pseudogene 3 |
23789 |
0.13 |
chr10_92556536_92557110 | 3.83 |
Gm4800 |
predicted gene 4800 |
13153 |
0.16 |
chr6_15639488_15639689 | 3.81 |
Gm44039 |
predicted gene, 44039 |
3464 |
0.35 |
chr2_10525644_10525960 | 3.80 |
Mir669h |
microRNA 669h |
7647 |
0.01 |
chr2_80129220_80129421 | 3.80 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
138 |
0.96 |
chr8_99414741_99415068 | 3.80 |
Cdh8 |
cadherin 8 |
1415 |
0.4 |
chr4_39345356_39345507 | 3.78 |
Gm23607 |
predicted gene, 23607 |
49968 |
0.14 |
chr1_6734835_6735004 | 3.78 |
St18 |
suppression of tumorigenicity 18 |
49 |
0.99 |
chr4_27429531_27429705 | 3.78 |
Gm11901 |
predicted gene 11901 |
113560 |
0.07 |
chr10_59090684_59090879 | 3.77 |
Sh3rf3 |
SH3 domain containing ring finger 3 |
10747 |
0.24 |
chr9_26690126_26690338 | 3.77 |
Gm48393 |
predicted gene, 48393 |
40942 |
0.15 |
chr14_19720139_19720325 | 3.77 |
Gm49341 |
predicted gene, 49341 |
23023 |
0.12 |
chr1_66320866_66321435 | 3.76 |
Map2 |
microtubule-associated protein 2 |
569 |
0.75 |
chr14_11960676_11960864 | 3.75 |
Gm3848 |
predicted gene 3848 |
20438 |
0.22 |
chr8_23562129_23562317 | 3.74 |
Zmat4 |
zinc finger, matrin type 4 |
73796 |
0.11 |
chr3_56981029_56981302 | 3.74 |
Gm22269 |
predicted gene, 22269 |
72985 |
0.12 |
chr14_22037282_22037433 | 3.74 |
Gm7480 |
predicted gene 7480 |
1254 |
0.4 |
chr14_9597570_9597992 | 3.71 |
Gm48371 |
predicted gene, 48371 |
128226 |
0.06 |
chr3_42111396_42111547 | 3.70 |
Gm37846 |
predicted gene, 37846 |
52394 |
0.16 |
chr8_12126666_12127044 | 3.70 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
151964 |
0.03 |
chr12_48284505_48284715 | 3.70 |
Gm48587 |
predicted gene, 48587 |
210609 |
0.02 |
chr5_70842284_70842796 | 3.69 |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
77 |
0.99 |
chr1_137373621_137374166 | 3.69 |
Gm23534 |
predicted gene, 23534 |
6646 |
0.26 |
chr4_53253649_53254014 | 3.69 |
4930522O17Rik |
RIKEN cDNA 4930522O17 gene |
7635 |
0.18 |
chr2_51831341_51831505 | 3.68 |
Gm13492 |
predicted gene 13492 |
12854 |
0.2 |
chr5_40295409_40295582 | 3.68 |
Gm2810 |
predicted pseudogene 2810 |
32943 |
0.24 |
chr1_67558856_67559007 | 3.68 |
Kif22-ps |
kinesin family member 22, pseudogene |
26122 |
0.23 |
chr10_18360177_18360562 | 3.65 |
Gm18942 |
predicted gene, 18942 |
23128 |
0.17 |
chr2_56257440_56257969 | 3.64 |
Gm13518 |
predicted gene 13518 |
217851 |
0.02 |
chr6_6604244_6604395 | 3.64 |
Sem1 |
SEM1, 26S proteasome complex subunit |
25656 |
0.18 |
chr2_49719024_49719250 | 3.62 |
Kif5c |
kinesin family member 5C |
3430 |
0.29 |
chr14_35244974_35245125 | 3.62 |
Gm49034 |
predicted gene, 49034 |
25611 |
0.26 |
chr6_17796921_17797464 | 3.62 |
Gm26738 |
predicted gene, 26738 |
37993 |
0.12 |
chr16_79870693_79870877 | 3.61 |
Rps19-ps12 |
ribosomal protein S19, pseudogene 12 |
44086 |
0.2 |
chr15_26021931_26022113 | 3.59 |
Zfp622 |
zinc finger protein 622 |
26986 |
0.18 |
chr15_84812869_84813054 | 3.59 |
Phf21b |
PHD finger protein 21B |
9404 |
0.18 |
chr14_35112923_35113111 | 3.59 |
Gm49034 |
predicted gene, 49034 |
106421 |
0.07 |
chr10_70952624_70952802 | 3.59 |
Bicc1 |
BicC family RNA binding protein 1 |
4224 |
0.2 |
chr6_54554355_54554906 | 3.58 |
Scrn1 |
secernin 1 |
175 |
0.95 |
chr15_95217343_95217494 | 3.58 |
1700129L04Rik |
RIKEN cDNA 1700129L04 gene |
55024 |
0.17 |
chr10_38103605_38103756 | 3.58 |
Gm31378 |
predicted gene, 31378 |
18381 |
0.22 |
chr12_33035669_33036432 | 3.58 |
Cdhr3 |
cadherin-related family member 3 |
16936 |
0.14 |
chr7_96865260_96865776 | 3.58 |
Gm25712 |
predicted gene, 25712 |
2139 |
0.28 |
chr2_152069243_152069466 | 3.57 |
AA387200 |
expressed sequence AA387200 |
7454 |
0.15 |
chr2_171847235_171847407 | 3.57 |
1700028P15Rik |
RIKEN cDNA 1700028P15 gene |
114810 |
0.06 |
chr14_13651882_13652062 | 3.57 |
Sntn |
sentan, cilia apical structure protein |
18904 |
0.24 |
chr10_52742737_52743261 | 3.56 |
Gm47624 |
predicted gene, 47624 |
49161 |
0.11 |
chr14_59737850_59738006 | 3.55 |
Gm19716 |
predicted gene, 19716 |
95380 |
0.07 |
chr14_38825108_38825292 | 3.55 |
Nrg3os |
neuregulin 3, opposite strand |
73102 |
0.12 |
chr12_39027318_39027481 | 3.54 |
Gm19563 |
predicted gene, 19563 |
28745 |
0.18 |
chr7_74687903_74688273 | 3.54 |
Gm7726 |
predicted gene 7726 |
11768 |
0.26 |
chr6_50777784_50778006 | 3.54 |
C530044C16Rik |
RIKEN cDNA C530044C16 gene |
1571 |
0.34 |
chrX_93377714_93377865 | 3.54 |
Arx |
aristaless related homeobox |
91279 |
0.08 |
chr4_138689318_138689498 | 3.54 |
Pla2g2c |
phospholipase A2, group IIC |
35384 |
0.12 |
chr12_39301178_39301567 | 3.53 |
Gm18591 |
predicted gene, 18591 |
92480 |
0.08 |
chr14_12346462_12346680 | 3.52 |
Fezf2 |
Fez family zinc finger 2 |
612 |
0.63 |
chr19_14777449_14777621 | 3.52 |
Gm26026 |
predicted gene, 26026 |
59055 |
0.15 |
chr14_62003120_62003302 | 3.51 |
Gm47953 |
predicted gene, 47953 |
9108 |
0.26 |
chr12_47163286_47163464 | 3.51 |
Gm36971 |
predicted gene, 36971 |
1667 |
0.48 |
chr17_44398035_44398193 | 3.51 |
Gm49872 |
predicted gene, 49872 |
30211 |
0.23 |
chr10_19329521_19329721 | 3.51 |
Olig3 |
oligodendrocyte transcription factor 3 |
26912 |
0.17 |
chr2_28780313_28780498 | 3.50 |
Gm13385 |
predicted gene 13385 |
13164 |
0.13 |
chr7_95991206_95991793 | 3.49 |
Gm5037 |
predicted gene 5037 |
78113 |
0.11 |
chr13_71507941_71508418 | 3.49 |
1700112M02Rik |
RIKEN cDNA 1700112M02 gene |
20572 |
0.26 |
chr16_71497335_71497513 | 3.48 |
Gm22797 |
predicted gene, 22797 |
166364 |
0.04 |
chr4_85250379_85250530 | 3.48 |
Gm12413 |
predicted gene 12413 |
4692 |
0.28 |
chrX_9696032_9696343 | 3.47 |
Dynlt3 |
dynein light chain Tctex-type 3 |
33184 |
0.19 |
chr3_141936313_141936536 | 3.47 |
Bmpr1b |
bone morphogenetic protein receptor, type 1B |
4901 |
0.33 |
chr8_92167277_92167548 | 3.45 |
Gm45335 |
predicted gene 45335 |
5175 |
0.21 |
chr7_29071400_29071669 | 3.45 |
Gm26604 |
predicted gene, 26604 |
69 |
0.87 |
chr1_5232314_5232482 | 3.43 |
Gm7182 |
predicted gene 7182 |
44939 |
0.16 |
chr2_116324478_116324629 | 3.42 |
Gm13991 |
predicted gene 13991 |
203937 |
0.02 |
chr2_65956896_65957070 | 3.42 |
Gm13617 |
predicted gene 13617 |
2913 |
0.28 |
chr19_25607993_25608244 | 3.42 |
Dmrt3 |
doublesex and mab-3 related transcription factor 3 |
2183 |
0.36 |
chr18_78455374_78455574 | 3.41 |
4931439C15Rik |
RIKEN cDNA 4931439C15 gene |
21404 |
0.24 |
chr13_78181182_78181614 | 3.41 |
Gm38604 |
predicted gene, 38604 |
1761 |
0.26 |
chr10_17202862_17203093 | 3.41 |
Gm25382 |
predicted gene, 25382 |
86173 |
0.09 |
chr11_19350855_19351213 | 3.40 |
Gm12025 |
predicted gene 12025 |
10035 |
0.25 |
chr6_141050341_141050632 | 3.40 |
Gm43927 |
predicted gene, 43927 |
42201 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.7 | 9.9 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.5 | 4.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.5 | 8.7 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.3 | 3.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.3 | 3.9 | GO:0060166 | olfactory pit development(GO:0060166) |
1.3 | 5.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.2 | 8.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.2 | 5.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.1 | 3.4 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.1 | 3.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.1 | 4.3 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.0 | 4.9 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.9 | 1.9 | GO:0031223 | auditory behavior(GO:0031223) |
0.9 | 3.8 | GO:0030035 | microspike assembly(GO:0030035) |
0.9 | 2.7 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.9 | 1.8 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.9 | 2.6 | GO:0021856 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.9 | 2.6 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.9 | 3.4 | GO:0060594 | mammary gland specification(GO:0060594) |
0.8 | 2.5 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.8 | 8.9 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.8 | 0.8 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.8 | 4.8 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.8 | 3.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.8 | 2.3 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.7 | 3.0 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.7 | 1.4 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.7 | 2.9 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.7 | 2.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.7 | 0.7 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.7 | 2.8 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.7 | 1.4 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.7 | 6.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.6 | 1.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.6 | 1.9 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.6 | 1.3 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.6 | 1.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.6 | 1.9 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.6 | 1.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.6 | 1.8 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.6 | 0.6 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.6 | 0.6 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.6 | 1.8 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.6 | 1.8 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.6 | 2.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.6 | 1.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.6 | 4.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.6 | 2.3 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.6 | 1.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.6 | 1.7 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.6 | 3.4 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.6 | 5.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.5 | 0.5 | GO:0021756 | striatum development(GO:0021756) |
0.5 | 2.7 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.5 | 2.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.5 | 1.6 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.5 | 1.6 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.5 | 1.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.5 | 2.6 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.5 | 2.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.5 | 1.5 | GO:0061743 | motor learning(GO:0061743) |
0.5 | 2.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.5 | 1.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.5 | 1.5 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 8.4 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.5 | 1.9 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.5 | 1.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.5 | 1.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.5 | 2.8 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.5 | 1.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.5 | 0.9 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.5 | 0.5 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.5 | 2.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.5 | 3.6 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.4 | 3.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.4 | 4.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.4 | 1.7 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.4 | 0.9 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.4 | 2.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.4 | 0.9 | GO:0046959 | habituation(GO:0046959) |
0.4 | 1.3 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.4 | 6.3 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.4 | 1.7 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.4 | 1.2 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.4 | 0.4 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.4 | 0.8 | GO:0007412 | axon target recognition(GO:0007412) |
0.4 | 1.6 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 1.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.4 | 1.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.4 | 1.2 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.4 | 0.8 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.4 | 1.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.4 | 2.3 | GO:0060581 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.4 | 0.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.4 | 1.1 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.4 | 1.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.4 | 4.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.4 | 1.1 | GO:0030070 | insulin processing(GO:0030070) |
0.4 | 1.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.4 | 1.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 2.8 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.3 | 1.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 0.7 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.3 | 5.9 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 0.7 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.3 | 0.7 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.3 | 1.0 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.3 | 1.4 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.3 | 0.7 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.3 | 2.3 | GO:0001553 | luteinization(GO:0001553) |
0.3 | 0.3 | GO:0048880 | sensory system development(GO:0048880) |
0.3 | 1.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 7.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 1.0 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.3 | 0.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 2.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 1.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 0.6 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.3 | 1.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 0.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 1.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 0.9 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.3 | 0.9 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.3 | 0.9 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.3 | 0.6 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.3 | 1.5 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.3 | 1.5 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.3 | 1.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.3 | 1.2 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 3.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 1.8 | GO:0022605 | oogenesis stage(GO:0022605) |
0.3 | 0.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 1.8 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.3 | 0.9 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.3 | 0.3 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.3 | 0.6 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.3 | 2.0 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 0.8 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.3 | 0.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.3 | 0.6 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.3 | 2.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 1.4 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.3 | 1.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.3 | 0.8 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.3 | 2.2 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.3 | 0.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.3 | 1.1 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.8 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.3 | 22.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 1.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 0.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.3 | 1.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 1.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 0.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.3 | 1.5 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.2 | 1.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 1.5 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 1.0 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.2 | 0.5 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 0.5 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.2 | 1.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.2 | 2.4 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 1.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.5 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 1.9 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 0.7 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 1.2 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.2 | 1.1 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 0.5 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.2 | 0.9 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 1.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 0.2 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 0.7 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 0.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.7 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 0.4 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.2 | 0.2 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.2 | 0.4 | GO:0071435 | potassium ion export(GO:0071435) |
0.2 | 0.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 1.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 0.6 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.6 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 2.1 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 0.8 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 1.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.2 | 0.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.2 | 0.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 0.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.2 | 0.8 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.2 | 1.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 0.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 0.8 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 0.6 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.2 | 1.5 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 0.8 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.4 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.2 | 0.6 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.2 | 0.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 0.6 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 0.6 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.2 | 1.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.5 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.7 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.2 | 0.2 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.2 | 0.4 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.2 | 1.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 0.7 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.4 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 0.5 | GO:0097503 | sialylation(GO:0097503) |
0.2 | 0.3 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 1.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 1.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 0.3 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.2 | 0.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.3 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.2 | 0.5 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.2 | 1.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 1.4 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.2 | 0.5 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.2 | 0.2 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.2 | 0.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.2 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.2 | 1.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.5 | GO:0090427 | activation of meiosis(GO:0090427) |
0.2 | 0.2 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.2 | 0.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 1.7 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.2 | 0.5 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 0.3 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 0.8 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.2 | 0.5 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.6 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.6 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.3 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.1 | 0.4 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.4 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 2.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.6 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.7 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.1 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 1.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 1.0 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.1 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.1 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.1 | 0.1 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.7 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.3 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.7 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.1 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.1 | 0.3 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.4 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.3 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 0.4 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.7 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.1 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.7 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.4 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.6 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.1 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.5 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.5 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.6 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.1 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.1 | 0.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.5 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 1.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.2 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.1 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.4 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.2 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 | 0.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.6 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.2 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.1 | 0.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.2 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.1 | 0.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 0.1 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 0.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.4 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.1 | 1.7 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.1 | 0.2 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 0.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 1.2 | GO:0001964 | startle response(GO:0001964) |
0.1 | 1.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.4 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.3 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.1 | 0.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.2 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 | 0.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.1 | GO:0045632 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
0.1 | 0.7 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 1.4 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.9 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.1 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 0.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.1 | 0.4 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.3 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.5 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.2 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.2 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.3 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.5 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.1 | 0.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.2 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.3 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.4 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.2 | GO:0099515 | vesicle transport along actin filament(GO:0030050) actin filament-based transport(GO:0099515) |
0.1 | 0.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.1 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.3 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.4 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.3 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
0.1 | 0.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.1 | 3.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 1.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 0.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.2 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.1 | 0.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.3 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.2 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.1 | 0.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.1 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.1 | 0.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.8 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 0.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.2 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.2 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.2 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.1 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.6 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.1 | 0.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.2 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.1 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.6 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.2 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.3 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.2 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.6 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.1 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.2 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.3 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.1 | 0.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.2 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 0.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.1 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.1 | 0.2 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.6 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.3 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.1 | GO:0014848 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
0.1 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.2 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.0 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.0 | 1.1 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 1.0 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.0 | 0.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.0 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.0 | 0.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.0 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 1.0 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.2 | GO:2000380 | regulation of mesoderm development(GO:2000380) |
0.0 | 0.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.1 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.0 | 0.1 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 1.0 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.2 | GO:0072044 | collecting duct development(GO:0072044) |
0.0 | 0.2 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.0 | 0.0 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.0 | 0.0 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.0 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.0 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.0 | 0.1 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.0 | 0.3 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 0.0 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.0 | 0.1 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 1.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.0 | 0.2 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.1 | GO:0030540 | female genitalia development(GO:0030540) |
0.0 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.1 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.0 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.9 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.2 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.0 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.0 | 0.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.1 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.0 | 0.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.1 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.1 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.0 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 0.2 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.1 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.0 | 0.2 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.2 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.0 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.0 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0045113 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.0 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.0 | 0.1 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.0 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.2 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 0.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.1 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.0 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.0 | 1.5 | GO:0071804 | cellular potassium ion transport(GO:0071804) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.0 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.0 | 0.0 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.0 | 0.0 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.0 | 0.0 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.0 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.0 | 0.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.0 | 0.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.0 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.0 | 0.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.0 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.1 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.7 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.0 | 0.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 0.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.0 | 0.0 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.0 | 0.0 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.1 | 7.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.8 | 3.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.7 | 2.8 | GO:0033010 | paranodal junction(GO:0033010) |
0.6 | 6.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.6 | 2.9 | GO:0097433 | dense body(GO:0097433) |
0.6 | 4.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.6 | 1.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.5 | 7.4 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 3.2 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.5 | 1.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.5 | 2.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 4.5 | GO:0043194 | axon initial segment(GO:0043194) |
0.4 | 4.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 0.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.4 | 1.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.4 | 7.1 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.4 | 5.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 2.7 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.4 | 3.4 | GO:0005883 | neurofilament(GO:0005883) |
0.4 | 1.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 1.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.4 | 1.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.3 | 7.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 1.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 1.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 0.9 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 2.4 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 0.9 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 1.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 1.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.3 | 2.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 3.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 0.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 0.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 11.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 6.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 1.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 6.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 0.9 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 1.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 1.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 0.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 2.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 1.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 0.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 0.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 1.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 0.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 1.6 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 2.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 2.0 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.7 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 1.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.5 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 1.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.4 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.9 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 0.4 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 5.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 1.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.3 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 1.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 1.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.6 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.6 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.6 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 3.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 1.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.3 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.8 | GO:0033655 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.1 | 9.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.3 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.7 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 3.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 5.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 4.8 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.8 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.4 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.7 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 1.2 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 2.8 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.4 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 1.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 1.1 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 0.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.1 | GO:0097449 | astrocyte projection(GO:0097449) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.1 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.7 | 17.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.0 | 9.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.6 | 4.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.1 | 3.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.0 | 4.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.9 | 3.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.9 | 2.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.9 | 2.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.9 | 2.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.8 | 3.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.7 | 5.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.7 | 5.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.6 | 5.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.6 | 1.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 3.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 1.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.6 | 2.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.6 | 2.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.6 | 4.4 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.5 | 1.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.5 | 2.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.5 | 2.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.5 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.5 | 2.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.5 | 0.5 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.4 | 1.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 2.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 1.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.4 | 2.5 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.4 | 4.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.4 | 1.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 1.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 1.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 0.8 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.4 | 2.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.4 | 5.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 3.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.4 | 1.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 1.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 2.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.4 | 1.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 1.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 4.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 1.7 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 0.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 1.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 1.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 3.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.3 | 6.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 0.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 1.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 1.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 1.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.3 | 0.9 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 0.8 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 1.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 2.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 0.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 1.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 5.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 1.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 0.5 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.2 | 4.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 4.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 1.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 2.0 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 0.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 1.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 2.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 0.2 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.2 | 0.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 4.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 0.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 1.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 1.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 1.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 0.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 0.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.5 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.2 | 0.9 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 0.7 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 1.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 0.9 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 0.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 1.0 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 1.5 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 0.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 1.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 0.5 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 3.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 0.8 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 0.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 3.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 1.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.6 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 1.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 1.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 1.2 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 0.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.7 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.1 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.5 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 1.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 1.8 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 1.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.6 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.4 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 1.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 1.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 1.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.8 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.4 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.3 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 1.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 1.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.3 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 0.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 1.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 2.1 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 2.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 0.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.8 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 1.5 | GO:0052712 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 2.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.8 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.5 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.1 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 1.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.3 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 1.1 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.2 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.1 | GO:0032564 | dATP binding(GO:0032564) |
0.0 | 1.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 1.0 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 1.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.1 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.0 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.0 | 0.4 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.0 | 0.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 1.7 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 0.0 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.0 | 0.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 1.2 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.2 | GO:0070694 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.0 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.0 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.0 | 0.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 1.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.8 | 2.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.4 | 0.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 3.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 0.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 9.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 5.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 2.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 1.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 1.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.3 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 9.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.5 | 7.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 6.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.4 | 4.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 7.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 8.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 0.3 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.3 | 5.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 2.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 2.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 2.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 3.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 9.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 1.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 4.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 0.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 1.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 1.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 3.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 3.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 2.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 2.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 3.9 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 1.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.9 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 1.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 1.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.2 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 2.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 2.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.6 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.0 | 0.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.0 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.2 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |